1. Home
  2. NAZ vs CGEN Comparison

NAZ vs CGEN Comparison

Compare NAZ & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

N/A

Current Price

$12.52

Market Cap

146.0M

Sector

Finance

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

N/A

Current Price

$2.21

Market Cap

148.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NAZ
CGEN
Founded
1992
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.0M
148.7M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
NAZ
CGEN
Price
$12.52
$2.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
29.9K
295.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$58.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.40
$1.13
52 Week High
$12.73
$2.38

Technical Indicators

Market Signals
Indicator
NAZ
CGEN
Relative Strength Index (RSI) 74.92 63.58
Support Level $11.70 $1.45
Resistance Level N/A $2.36
Average True Range (ATR) 0.10 0.15
MACD 0.05 0.04
Stochastic Oscillator 84.80 83.85

Price Performance

Historical Comparison
NAZ
CGEN

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: